Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 140
interventional 97
Observational 42
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Behavioral 32
Drug 32
Other 11
Device 6
Drug|placebo 4
Biological 3
Dietary Supplement 2
Behavioral|Drug 1
Behavioral|Other 1
Biological|placebo 1
Dietary Supplement|Drug 1
Drug|Other|placebo 1
placebo 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 45
South Africa 6
NA 5
Zambia 4
Brazil 3
Canada 3
France 3
Zimbabwe 3
Belgium 2
Mozambique 2
Spain 2
Botswana 1
Chile 1
Colombia 1
Denmark 1
Ethiopia 1
Finland 1
Greece 1
Haiti 1
Indonesia|Ukraine|Vietnam 1
Kenya 1
Mali 1
Nepal 1
Swaziland 1
Tanzania 1
Tanzania|Uganda|Zimbabwe 1
Thailand 1
Ukraine 1
United States|Puerto Rico 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 62
2 10
3 8
4 6
5 2
6 1
7 1
9 1
10 2
17 1
27 1
40 1
42 1

Phase

Phase Study_Count
N/A 52
Phase 2 13
Phase 1 12
Phase 3 10
Phase 4 7
Phase 1/Phase 2 2
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 15
2 50
3 7
4 3
6 1
NA 21

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3 Phase.4
Min. 23 15.00 12.00000 10.00 16.00000 20.00 44.0
1st Qu. 23 84.50 19.00000 45.25 35.00000 52.25 48.5
Median 23 215.00 26.00000 80.50 51.00000 470.50 86.0
Mean 23 534.76 37.63636 80.50 87.16667 3385.50 150.0
3rd Qu. 23 458.50 52.50000 115.75 132.50000 1246.00 184.5
Max. 23 8080.00 100.00000 151.00 223.00000 24111.00 454.0

Trial Group Type

group_type Group_Count
Experimental 76
Active Comparator 36
No Intervention 24
NA 21
Placebo Comparator 11
Other 6
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 56
Single Group Assignment 22
NA 11
Crossover Assignment 5
Factorial Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 51
Prevention 17
Supportive Care 12
Health Services Research 9
Diagnostic 2
Other 2
NA 2
Basic Science 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 17
France 10
NA 4
Argentina|Brazil|Peru 1
Australia 1
Belgium 1
Brazil 1
Cambodia 1
Canada 1
Ireland|United Kingdom 1
Mali 1
Mozambique 1
South Africa|Zambia 1
United States|Kenya 1

Sites per Study

Site_count Study_Count
1 31
2 4
3 2
4 1
6 1
8 1
12 1
15 1

Enrollment Metrics

Measure Observational
Min 10.0000
1st Qu 50.0000
Median 160.0000
Mean 461.6829
3rd Qu 541.0000
Max 3554.0000

Observation Model

observational_model Study_Count
Cohort 20
NA 8
Other 4
Case-Control 3
Case-Only 3
Case Control 2
Ecologic or Community 2

Time Perspective

time_perspective Study_Count
Prospective 26
Cross-Sectional 6
NA 6
Retrospective 3
Other 1

Registries

Studies by Country

Country Study_Count
Chile 1

Sites per Study

Site_count Study_Count
2 1

Enrollment Metrics

Measure Registries
Min 1200
1st Qu 1200
Median 1200
Mean 1200
3rd Qu 1200
Max 1200

Registry Model

observational_model Study_Count
Other 1

Time Perspective

time_perspective Study_Count
Prospective 1

Follow-up

target_duration Study_Count
1 Year 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03374358 Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir https://ClinicalTrials.gov/show/NCT03374358 Completed Helsinki University Central Hospital 2019-11-02
NCT03367130 Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal https://ClinicalTrials.gov/show/NCT03367130 Completed Tokyo University 2018-06-30
NCT03333083 Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen https://ClinicalTrials.gov/show/NCT03333083 Recruiting Hospital Clinic of Barcelona 2020-03-30
NCT03311945 Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM https://ClinicalTrials.gov/show/NCT03311945 Recruiting Hospital Clinic of Barcelona 2020-03-30
NCT03292913 Positive Health Check Evaluation Trial https://ClinicalTrials.gov/show/NCT03292913 Active, not recruiting RTI International 2020-10-31
NCT03218839 Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males https://ClinicalTrials.gov/show/NCT03218839 Completed University of Washington 2016-02-29
NCT03213028 Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy https://ClinicalTrials.gov/show/NCT03213028 Completed University of Pennsylvania 2018-08-10
NCT03134924 Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention “WASH-2” https://ClinicalTrials.gov/show/NCT03134924 Completed University of Miami 2014-02-05
NCT03124914 Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV https://ClinicalTrials.gov/show/NCT03124914 Completed Centre Hospitalier Universitaire de Nice 2018-04-19
NCT03073421 Positive Pregnancy Program https://ClinicalTrials.gov/show/NCT03073421 Completed St. Michael’s Hospital, Toronto 2016-09-01
NCT03004170 Telephone Counseling to Enhance the Quality and Safety of Romantic and Sexual Relationships in People Living and Aging With HIV https://ClinicalTrials.gov/show/NCT03004170 Active, not recruiting Oregon Health and Science University 2020-12-31
NCT02994329 Community-based Distribution of Oral HIV Self-testing Kits https://ClinicalTrials.gov/show/NCT02994329 Completed Zambart 2017-09-30
NCT02938377 Alcohol Research Consortium in HIV-Intervention Research Arm https://ClinicalTrials.gov/show/NCT02938377 Recruiting University of Alabama at Birmingham 2021-08-31
NCT02935296 Integrated Treatment and Prevention for People Who Inject Drugs https://ClinicalTrials.gov/show/NCT02935296 Completed HIV Prevention Trials Network 2017-06-16
NCT02921516 Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings https://ClinicalTrials.gov/show/NCT02921516 Completed Florida International University 2018-05-31
NCT02833441 The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes https://ClinicalTrials.gov/show/NCT02833441 Completed University of Zimbabwe 2018-03-31
NCT02689895 Etiology of Treatment Failure in HIV Positive Children and Adolescents on Boosted Protease Inhibitor-based Regimens https://ClinicalTrials.gov/show/NCT02689895 Completed University of Zimbabwe 2017-01-31
NCT02677675 Effectiveness of Mobile Phone Technology on Adherence and Treatment Outcomes Among HIV Positive Patients on ART https://ClinicalTrials.gov/show/NCT02677675 Completed Universiti Putra Malaysia 2014-12-31
NCT02676167 Public Health Targeting of PrEP at HIV Positives’ Bridging Networks https://ClinicalTrials.gov/show/NCT02676167 Completed University of Chicago 2019-05-31
NCT02590354 Analytical Treatment Interruption in HIV Positive Patients https://ClinicalTrials.gov/show/NCT02590354 Completed Institute of Tropical Medicine, Belgium 2018-06-22
NCT03397420 Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland https://ClinicalTrials.gov/show/NCT03397420 Completed Elizabeth Glaser Pediatric AIDS Foundation 2018-10-30
NCT02546271 A Small-group Intervention to Reduce HIV Sexual Transmission Risk Behavior Among HIV-positive Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT02546271 Completed Ryerson University 2013-11-30
NCT02535429 Massage Therapy for HIV-positive People : Effects on Anxiety, Depression, Hyperventilation and Quality of Life https://ClinicalTrials.gov/show/NCT02535429 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2015-12-31
NCT02371265 Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique https://ClinicalTrials.gov/show/NCT02371265 Completed University of Washington 2015-08-31
NCT02338024 Enhancing Linkage to HIV Care for Newly Detected HIV-positive Persons in Ukraine https://ClinicalTrials.gov/show/NCT02338024 Completed Ukrainian Institute on Public Health Policy 2017-10-03
NCT02190643 Improving Nicotine Patch Adherence Among Latino HIV-Positive Smokers https://ClinicalTrials.gov/show/NCT02190643 Completed RAND 2015-11-30
NCT02153788 Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia https://ClinicalTrials.gov/show/NCT02153788 Completed Duke University 2010-09-30
NCT01296113 Chemotherapy for Lung Cancer in HIV-positive Patients https://ClinicalTrials.gov/show/NCT01296113 Completed Intergroupe Francophone de Cancerologie Thoracique 2016-01-31
NCT01295034 Vitamin D Supplements for HIV-positive Patients on cART https://ClinicalTrials.gov/show/NCT01295034 Completed Icahn School of Medicine at Mount Sinai 2015-06-30
NCT02029430 A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi’s Sarcoma https://ClinicalTrials.gov/show/NCT02029430 Completed CytRx 2015-12-31
NCT02012556 Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients https://ClinicalTrials.gov/show/NCT02012556 Completed Theratechnologies 2008-07-31
NCT02011958 Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. https://ClinicalTrials.gov/show/NCT02011958 Completed Drugs for Neglected Diseases 2016-08-31
NCT01957917 Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania https://ClinicalTrials.gov/show/NCT01957917 Completed University of California, Berkeley 2016-10-31
NCT01941121 CCTG 593: Testing and Linkage to Care https://ClinicalTrials.gov/show/NCT01941121 Active, not recruiting University of California, San Diego 2018-01-22
NCT01910493 Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique https://ClinicalTrials.gov/show/NCT01910493 Completed Absolute Return for Kids 2013-05-31
NCT01898754 Oligonucleotide Ligation Assay (OLA) Resistance Study https://ClinicalTrials.gov/show/NCT01898754 Completed University of Washington 2016-12-31
NCT01881971 Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center https://ClinicalTrials.gov/show/NCT01881971 Completed University of Pittsburgh 2015-11-30
NCT01818258 IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children https://ClinicalTrials.gov/show/NCT01818258 Completed International Maternal Pediatric Adolescent AIDS Clinical Trials Group 2017-04-11
NCT01816828 Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT01816828 Completed Ryerson University 2018-08-31
NCT01751620 Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care https://ClinicalTrials.gov/show/NCT01751620 Completed University of North Carolina, Chapel Hill 2015-06-30
NCT01733927 An Evaluation of a Rapid Test for HIV https://ClinicalTrials.gov/show/NCT01733927 Completed Pontificia Universidad Catolica de Chile 2010-11-30
NCT01723956 Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women https://ClinicalTrials.gov/show/NCT01723956 Completed University of Witwatersrand, South Africa 2014-08-31
NCT01721798 Comparison of Two IUDs Among Cape Town HIV-positive Women https://ClinicalTrials.gov/show/NCT01721798 Completed FHI 360 2018-07-13
NCT01689545 Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU https://ClinicalTrials.gov/show/NCT01689545 Completed Johns Hopkins Bloomberg School of Public Health 2013-04-30
NCT01537367 Intervention to Retain HIV-positive Patients in Medical Care https://ClinicalTrials.gov/show/NCT01537367 Completed Centers for Disease Control and Prevention 2012-02-29
NCT01499706 Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults https://ClinicalTrials.gov/show/NCT01499706 Completed Ohio University College of Osteopathic Medicine 2010-10-31
NCT01354210 Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth https://ClinicalTrials.gov/show/NCT01354210 Completed Ann & Robert H Lurie Children’s Hospital of Chicago 2013-03-31
NCT01350544 Treatment Advocacy Intervention for HIV-Positive African Americans https://ClinicalTrials.gov/show/NCT01350544 Completed Boston Children’s Hospital 2015-07-31
NCT04124536 Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women https://ClinicalTrials.gov/show/NCT04124536 Recruiting University of North Carolina, Chapel Hill 2021-01-31
NCT03858478 Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST https://ClinicalTrials.gov/show/NCT03858478 Recruiting Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba 2021-03-31
NCT03531749 Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate https://ClinicalTrials.gov/show/NCT03531749 Completed Universidad Autónoma del Estado de Hidalgo 2017-05-31
NCT03517358 Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol https://ClinicalTrials.gov/show/NCT03517358 Recruiting University of California, Davis 2019-12-31
NCT03483857 Peer Navigation to Improve Engagement in Care for HIV-Positive Men Who Have Sex With Men in Ehlanzeni, South Africa https://ClinicalTrials.gov/show/NCT03483857 Completed University of California, San Francisco 2018-06-29
NCT03432819 A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM https://ClinicalTrials.gov/show/NCT03432819 Active, not recruiting RAND 2020-08-31
NCT01246401 Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations https://ClinicalTrials.gov/show/NCT01246401 Completed Yale University 2016-03-31
NCT01211288 Longitudinal Study of Dental Implant Therapy in HIV Positive Patients https://ClinicalTrials.gov/show/NCT01211288 Completed University of Alabama at Birmingham 2019-04-01
NCT01174914 Effectiveness Study Low-Dose Naltrexone Versus ARV’s for HIV+ https://ClinicalTrials.gov/show/NCT01174914 Completed The Ojai Foundation 2010-03-31
NCT01140880 Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT01140880 Completed Friends Research Institute, Inc. 2013-03-31
NCT01122186 Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE) https://ClinicalTrials.gov/show/NCT01122186 Completed Hunter College of City University of New York 2012-01-31
NCT00990678 Study of Vitamin D Supplementation to Male HIV Sero-positive Patients https://ClinicalTrials.gov/show/NCT00990678 Completed Hvidovre University Hospital 2010-02-28
NCT00959361 Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00959361 Completed Hospital de Clinicas de Porto Alegre 2009-05-31
NCT00941889 The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata https://ClinicalTrials.gov/show/NCT00941889 Completed Washington University School of Medicine 2011-07-31
NCT01957748 CCTG 594: Engagement and Retention in Care for HIV+ https://ClinicalTrials.gov/show/NCT01957748 Active, not recruiting University of California, San Diego 2017-12-15
NCT01751594 Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT01751594 Completed University of North Carolina, Chapel Hill 2014-06-30
NCT00741637 Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults https://ClinicalTrials.gov/show/NCT00741637 Completed International Vaccine Institute 2011-04-30
NCT00721305 Lovastatin: Immunomodulatory Value Evaluation https://ClinicalTrials.gov/show/NCT00721305 Completed Universidad de Antioquia 2011-07-31
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay https://ClinicalTrials.gov/show/NCT00686205 Completed Abbott Diagnostics Division 2008-08-31
NCT00659971 Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis https://ClinicalTrials.gov/show/NCT00659971 Completed Pacgen Biopharmaceuticals Corporation 2008-06-30
NCT00551720 Motivation and Patch Treatment for HIV-positive Smokers https://ClinicalTrials.gov/show/NCT00551720 Completed National Institute on Drug Abuse (NIDA) NA
NCT00444977 Enhancing Oral Health Care Use by HIV Positive Individuals https://ClinicalTrials.gov/show/NCT00444977 Completed Columbia University 2009-12-31
NCT00429845 Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial https://ClinicalTrials.gov/show/NCT00429845 Completed Hospital de Clinicas de Porto Alegre NA
NCT00381212 A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. https://ClinicalTrials.gov/show/NCT00381212 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2008-02-29
NCT00367458 Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00367458 Completed National Institutes of Health Clinical Center (CC) 2008-06-19
NCT00343317 Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women https://ClinicalTrials.gov/show/NCT00343317 Completed University of KwaZulu NA
NCT00270530 Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia https://ClinicalTrials.gov/show/NCT00270530 Completed Center for International Health and Development NA
NCT00213083 Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission https://ClinicalTrials.gov/show/NCT00213083 Completed Population Council 2007-04-30
NCT00213005 Safety and Acceptability of Carraguard® in HIV Positive Women and Men https://ClinicalTrials.gov/show/NCT00213005 Completed Population Council NA
NCT00197678 Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women https://ClinicalTrials.gov/show/NCT00197678 Completed Harvard School of Public Health 2005-07-31
NCT00130819 Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants https://ClinicalTrials.gov/show/NCT00130819 Completed Johns Hopkins University 2009-04-30
NCT00116636 Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients https://ClinicalTrials.gov/show/NCT00116636 Completed Therapeutic Concepts NA
NCT00086710 Study of Enfuvirtide in HIV-Positive Subjects https://ClinicalTrials.gov/show/NCT00086710 Completed Trimeris NA
NCT00035893 The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART https://ClinicalTrials.gov/show/NCT00035893 Completed AIM ImmunoTech Inc. 2006-08-31
NCT00447798 Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users https://ClinicalTrials.gov/show/NCT00447798 Completed Columbia University 2011-03-31
NCT00009555 Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat https://ClinicalTrials.gov/show/NCT00009555 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00002321 A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis https://ClinicalTrials.gov/show/NCT00002321 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002243 A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment https://ClinicalTrials.gov/show/NCT00002243 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002171 A Study of Viracept in HIV-Positive Women https://ClinicalTrials.gov/show/NCT00002171 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002098 Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2’,3’-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients https://ClinicalTrials.gov/show/NCT00002098 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002033 A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease https://ClinicalTrials.gov/show/NCT00002033 Completed NIH AIDS Clinical Trials Information Service NA
NCT00001997 Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals https://ClinicalTrials.gov/show/NCT00001997 Completed NIH AIDS Clinical Trials Information Service NA
NCT00000772 A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals https://ClinicalTrials.gov/show/NCT00000772 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000735 A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC https://ClinicalTrials.gov/show/NCT00000735 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000667 A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells https://ClinicalTrials.gov/show/NCT00000667 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000664 Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals https://ClinicalTrials.gov/show/NCT00000664 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000648 A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals https://ClinicalTrials.gov/show/NCT00000648 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00000633 A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals https://ClinicalTrials.gov/show/NCT00000633 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001474 Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients https://ClinicalTrials.gov/show/NCT00001474 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04030689 Free HIV Testing in Private Biological Laboratories: A New Offer to Encourage HIV Testing https://ClinicalTrials.gov/show/NCT04030689 Recruiting Centre Hospitalier Universitaire de Nice 2020-06-30
NCT03369743 Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD) https://ClinicalTrials.gov/show/NCT03369743 Completed Centre de Recherches et d’Etude sur la Pathologie Tropicale et le Sida 2018-06-30
NCT03290755 Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux https://ClinicalTrials.gov/show/NCT03290755 Completed University Hospital, Bordeaux 2018-03-13
NCT03215004 Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals https://ClinicalTrials.gov/show/NCT03215004 Recruiting American Gene Technologies International Inc. 2021-02-07
NCT03170414 Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients https://ClinicalTrials.gov/show/NCT03170414 Recruiting University of Minnesota 2022-12-31
NCT03139630 COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV—Infected Patients https://ClinicalTrials.gov/show/NCT03139630 Completed Saint Antoine University Hospital 2016-09-30
NCT03030768 Safer Conception Intervention for HIV-1 Serodiscordant Couples https://ClinicalTrials.gov/show/NCT03030768 Completed University of Washington 2018-05-31
NCT02154971 Assessment of Age-related Hearing Loss in HIV-1 Patients https://ClinicalTrials.gov/show/NCT02154971 Active, not recruiting Fondation Ophtalmologique Adolphe de Rothschild 2019-02-26
NCT02116374 Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients https://ClinicalTrials.gov/show/NCT02116374 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2016-06-30
NCT02082574 Prevalence of Cerebral Small Vessel Disease in HIV Infected Patients https://ClinicalTrials.gov/show/NCT02082574 Completed Fondation Ophtalmologique Adolphe de Rothschild 2016-06-30
NCT01311752 Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women https://ClinicalTrials.gov/show/NCT01311752 Completed French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2012-11-30
NCT02003989 Revealing Increased Axonal Loss in Treated HIV Patients https://ClinicalTrials.gov/show/NCT02003989 Completed Fondation Ophtalmologique Adolphe de Rothschild 2015-08-31
NCT01824628 Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts https://ClinicalTrials.gov/show/NCT01824628 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2013-10-31
NCT01813292 Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine https://ClinicalTrials.gov/show/NCT01813292 Completed Hopital Lariboisière 2014-05-31
NCT01748136 Screening for Lung Cancer in the HIV Patient https://ClinicalTrials.gov/show/NCT01748136 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2011-09-30
NCT01737047 The Effects of Ageing on the ‘Pharmacokinetic and Clinical Observations in People Over Fifty’ https://ClinicalTrials.gov/show/NCT01737047 Active, not recruiting Imperial College London 2021-01-31
NCT01701895 Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera https://ClinicalTrials.gov/show/NCT01701895 Completed University of North Carolina, Chapel Hill 2015-10-31
NCT01681914 Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique https://ClinicalTrials.gov/show/NCT01681914 Completed Vanderbilt University 2012-09-30
NCT01536912 Medical Marijuana Use in HIV+ Patients: Probability Survey https://ClinicalTrials.gov/show/NCT01536912 Completed Wayne State University 2014-12-31
NCT01536899 Medical Marijuana Use in HIV+ Patients Prospective Cohort Study https://ClinicalTrials.gov/show/NCT01536899 Completed Wayne State University 2017-06-30
NCT04044586 HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST) https://ClinicalTrials.gov/show/NCT04044586 Active, not recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2019-09-30
NCT03795415 ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali https://ClinicalTrials.gov/show/NCT03795415 Recruiting French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) 2020-02-29
NCT03777371 Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation https://ClinicalTrials.gov/show/NCT03777371 Completed Kanuni Sultan Suleyman Training and Research Hospital 2018-12-01
NCT03721796 Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions https://ClinicalTrials.gov/show/NCT03721796 Active, not recruiting Duke University 2023-11-30
NCT03449706 Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection https://ClinicalTrials.gov/show/NCT03449706 Recruiting University Hospital, Ghent 2023-01-01
NCT01154556 RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice https://ClinicalTrials.gov/show/NCT01154556 Completed Holdsworth House Medical Practice 2011-09-30
NCT01154543 Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes https://ClinicalTrials.gov/show/NCT01154543 Completed Holdsworth House Medical Practice 2013-01-31
NCT01152684 Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border https://ClinicalTrials.gov/show/NCT01152684 Completed University of California, San Diego 2013-01-31
NCT01034800 The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215 https://ClinicalTrials.gov/show/NCT01034800 Completed National Institutes of Health Clinical Center (CC) NA
NCT00981279 Profile of HIV Seropositive Patients https://ClinicalTrials.gov/show/NCT00981279 Completed Universidade Federal de Goias 2009-09-30
NCT00857350 The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment https://ClinicalTrials.gov/show/NCT00857350 Completed Yale University 2010-06-30
NCT01875588 Thinking and Memory Problems in People With HIV https://ClinicalTrials.gov/show/NCT01875588 Recruiting National Institutes of Health Clinical Center (CC) 2027-02-22
NCT01793467 Transplantation and the Use of Raltegravir in HIV-Infected Patients https://ClinicalTrials.gov/show/NCT01793467 Completed Duke University 2017-06-30
NCT03920969 Sport and Self Esteem in Patients Living With HIV https://ClinicalTrials.gov/show/NCT03920969 Recruiting Centre Hospitalier le Mans 2019-11-30
NCT00639145 Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol https://ClinicalTrials.gov/show/NCT00639145 Completed Elizabeth Glaser Pediatric AIDS Foundation 2012-12-31
NCT00341302 A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries https://ClinicalTrials.gov/show/NCT00341302 Completed National Institutes of Health Clinical Center (CC) NA
NCT00271882 PTSD and Risk Behavior in HIV Positive Female Adolescents https://ClinicalTrials.gov/show/NCT00271882 Completed University of North Carolina, Chapel Hill 2006-09-30
NCT00245531 Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs https://ClinicalTrials.gov/show/NCT00245531 Completed Johns Hopkins University 2010-06-30
NCT00106795 Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS https://ClinicalTrials.gov/show/NCT00106795 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001102 The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients https://ClinicalTrials.gov/show/NCT00001102 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00006171 Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma https://ClinicalTrials.gov/show/NCT00006171 Completed National Institutes of Health Clinical Center (CC) NA
NCT00012701 Measuring HIV Quality of Care https://ClinicalTrials.gov/show/NCT00012701 Completed VA Office of Research and Development NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04088916 Proviral DNA as a Target for HIV-1 Resistance Analysis https://ClinicalTrials.gov/show/NCT04088916 Recruiting University of Chile 2019-09-08